methotrexate has been researched along with Cephalgia Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boursiquot, R; Hanif, S; Jain, M; Krol, D; Rojas, J | 1 |
| Bernard-Medina, G; Chiquete, E; González-Cornejo, S; Gutiérrez-Ureña, S; Ramos-Gómez, EJ; Romero-Vargas, S; Ruiz-Sandoval, JL | 1 |
2 other study(ies) available for methotrexate and Cephalgia Syndromes
| Article | Year |
|---|---|
Syndrome of inappropriate antidiuretic hormone in a patient with leptomeningeal carcinomatosis.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Esophageal Neoplasms; Fatal Outcome; Headache Disorders; Humans; Inappropriate ADH Syndrome; Male; Meningeal Carcinomatosis; Methotrexate; Sodium Chloride, Dietary; Spinal Puncture | 2016 |
Idiopathic hypertrophic cranial pachymeningitis successfully treated with weekly subcutaneous methotrexate.
Topics: Cerebellar Diseases; Cranial Nerve Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Dura Mater; Female; Headache Disorders; Humans; Hypertrophy; Immunosuppressive Agents; Magnetic Resonance Imaging; Meningitis; Methotrexate; Middle Aged; Remission Induction; Treatment Outcome | 2006 |